|
|
Volumn 86, Issue 4, 2000, Pages 538-539
|
|
No effect of losartan on response to erythropoietin therapy in patients undergoing hemodialysis [20]
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ANGIOTENSIN 2 RECEPTOR ANTAGONIST;
CAPTOPRIL;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
ENALAPRIL;
FERRITIN;
HEMOGLOBIN;
IRON;
LOSARTAN;
RECOMBINANT ERYTHROPOIETIN;
TEMOCAPRIL;
ADULT;
AGED;
ANEMIA;
CLINICAL ARTICLE;
CLINICAL TRIAL;
CONTROLLED CLINICAL TRIAL;
CONTROLLED STUDY;
DRUG EFFICACY;
DRUG RESPONSE;
ERYTHROCYTOSIS;
FEMALE;
HEART LEFT VENTRICLE HYPERTROPHY;
HEMODIALYSIS;
HEMOGLOBIN DETERMINATION;
HUMAN;
HYPERTENSION;
IRON THERAPY;
KIDNEY TRANSPLANTATION;
LETTER;
MALE;
PRIORITY JOURNAL;
RANDOMIZED CONTROLLED TRIAL;
ANEMIA;
ANGIOTENSIN-CONVERTING ENZYME INHIBITORS;
ANTIHYPERTENSIVE AGENTS;
DRUG INTERACTIONS;
ERYTHROPOIETIN, RECOMBINANT;
FEMALE;
HUMANS;
KIDNEY FAILURE, CHRONIC;
LOSARTAN;
MALE;
MIDDLE AGED;
RENAL DIALYSIS;
|
|
EID: 0034528663
PISSN: 00282766
EISSN: None
Source Type: Journal
DOI: 10.1159/000045860 Document Type: Letter |
|
Times cited : (5)
|
|
References (9)
|
